Back
HFA Premium Access

Sequential cyclophosphamide-bortezomib-dexamethasone (CyBorD) unmasks the harmful cardiac effect of dexamethasone in primary (AL) cardiac amyloidosis

Session: Poster Session 1 - Comorbodities
Topic: Cancer/Cardiotoxicity
Speaker: Miss M. Kharoubi (Creteil, FR)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

Like

About the speaker

Miss Mounira Kharoubi

Creteil (France)
0 follower

29 more presentations in this session

Detection of cardiac dysfunction in asymptomatic cancer survivors with exercise strain echocardiography

Speaker: Doctor K. Lam (Murdoch, AU)

Access
Abstract
Like
Thumbnail

Echocardiography parameters as predictors of left ventricular ejection fraction reduction in cancer patients

Speaker: Doctor B. Sadeh (Tel Aviv, IL)

Access
Abstract
Slides
Like
Thumbnail

Characterization of the clinical and echocardiographic profile of a population of women with breast cancer.

Speaker: Doctor J. da Conceicao Pedro Pais (Evora, PT)

Access
Abstract
Like
Thumbnail

Basal renal function and its evolution in patients admitted for decompensated heart failure.

Access
Slides
Like
Thumbnail

Prevalence and prognostic value of comorbidities in patients with decompensated heart failure and acute kidney injury

Speaker: Doctor A. Klimenko (Moscow, RU)

Access
Like
Thumbnail

Access the full session

Poster Session 1 - Comorbodities

Speakers: Miss M. Kharoubi, Doctor K. Lam, Doctor B. Sadeh, Doctor J. da Conceicao Pedro Pais, Doctor A. Klimenko
Access
Like
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources